KOMO Biosciences is a non-viral targeted DNA insertion company developing platform technologies that enable the precise integration of large genetic payloads into defined genomic locations
KOMO Biosciences is a non-viral targeted DNA insertion company developing platform technologies that enable the precise integration of large genetic payloads into defined genomic locations. Through its proprietary KOMbine™ and KOMbineX™ platforms, KOMO provides foundational genome engineering infrastructure for applications across therapeutics, bioprocessing, agricultural biotechnology, and industrial life sciences.